Avista Capital Partners and Nordic Capital announce Public Tender Offer for Acino Holding
On October 2, 2013, Pharma Strategy Partners GmbH, a wholly-owned subsidiary of Avista Capital Partners and Nordic Capital, published the pre-announcement for a public tender offer for all publicly held shares of Acino Holding AG, Aesch BL, Switzerland. The offer price amounts to CHF 115 per share, corresponding to an equity value of CHF 398 million and an enterprise value of approximately CHF 540 million. The transaction is subject to a number of conditions, including an acceptance threshold of 66.67% of all Acino shares. The offer prospectus will be published on October 4, 2013.
Pharma Strategy Partners GmbH is being advised by Lenz & Staehelin in this transaction. The team is led by Corporate Partners Rudolf Tschäni and Hans-Jakob Diem and includes Finance Partner Marcel Tranchet, Corporate Partner Stephan Erni, Simone Ehrsam, Eric Meier and Andreas Hinsen (all Corporate) and Roland Fischer and Pascal Genoud (Financing).